ArticleNature communications2026

Hijacking innate immunity to enhance mRNA therapeutics by blocking IFN-P-body-XRN1 axis-mediated degradation.

Tinghong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.